✨ Dorothy ✨ Zelent

Dorothy Zelent has an extensive work experience in business development and scientific research. ✨ Dorothy ✨ currently holds the role of Sr. Business Development Manager at Veranova (formerly Johnson Matthey Health), which they started in June 2022. Prior to that, they worked at Johnson Matthey from July 2019 to May 2022 as a Sr. Business Development Manager.

Dorothy has also held key positions in other companies such as ImaBiotech, where they served as the Director of Business Development from July 2018 to July 2019. ✨ Dorothy ✨ was also the Director of Strategic Partnerships at ERT from 2017 to 2018.

Earlier in their career, Dorothy was the Director of North American Operations at Gentronix Limited from 2011 to 2017. ✨ Dorothy ✨ also worked as a Business Development Manager at Kayentis from 2008 to 2010.

Dorothy's expertise in scientific research is reflected in their previous roles at GlaxoSmithKline, where they were a Senior Scientist in the Metabolic Pathway CEDD from 2005 to 2008. ✨ Dorothy ✨ also worked as a Research Specialist at the University of Pennsylvania Diabetes Center from 2001 to 2005 and received research training at the same institution from 1999 to 2000.

Dorothy Zelent completed their Bachelor's degree in Biology, General from Villanova University, starting in 1998 and graduating in 2001. ✨ Dorothy ✨ then pursued a Master's degree in Molecular Biotechnology at the University of Pennsylvania, enrolling in 2002 and completing their studies in 2005. Prior to their higher education, Dorothy attended Jean XXIII, although the specific dates and degree information are not available.